[ad_1]
Close "AstraZeneca" Its vaccine has the ability to protect people from the corona immediately and its effectiveness lasts between 6 months and a full year.
On Saturday, the U.S. Food and Drug Administration granted emergency approval to use a treatment for Covid-19 developed by the biotech company. "Regeneron".
The approved drug was used to treat US President Donald Trump when he contracted COVID-19.
Purity "France brush" On US Food and Drug Administration official Stephen Hahn saying that "Allowing these monoclonal antibody therapies could allow patients to avoid hospitalization and reduce the burden on our healthcare system.".
For his part, the CEO of the company said "Regeneron"Leonard Schleifer, this is framing "An important step in the fight against Covid-19, as high-risk patients in the United States will be able to receive promising treatment early in the course of the infection.".
He was given the green light to try "Regeneron", Called "Region-Cove-2"It is a combination of two antibodies, which has been shown to reduce Covid-19 cases that require hospitalization or emergency rooms.
“>
The British network “Sky News” quoted Simson as saying that he wanted the treatment to be able to return to his normal life.
Simpson added: “During my work in the intensive care unit, I saw the effect of Corona on the injured, it was devastating for the patients and their families.”
“I haven’t seen my mom and dad since March, and I miss seeing my friends and hugging my daughters. This treatment gives us some hope, which is what everyone wants right now,” he added.
He indicated that front-line workers in the health sector are the ones who most need the vaccine due to the harsh working conditions they are going through, and pointed out that there are a large number of patients waiting to receive it as well.
And Simson got the treatment for “AstraZeneca,” which is based on antibodies, as the first person to benefit from it in a trial that will include 1,000 people in Britain.
AstraZeneca says that its vaccine has the ability to protect people from the corona immediately, and its effectiveness lasts between 6 months and a year.
On Saturday, the US Food and Drug Administration granted emergency approval to use a treatment for Covid-19 developed by the biotech company “Regeneron.”
The approved drug was used to treat US President Donald Trump when he contracted COVID-19.
“France Press” quoted US Food and Drug Administration official Stephen Hahn as saying that “allowing these monoclonal antibody treatments can allow patients to avoid hospitalization and reduce the burden on our health care system.”
For his part, the general director of “Regeneron”, Leonard Schleifer, said that this constitutes “an important step in the fight against Covid-19, since high-risk patients in the United States will be able to obtain a promising treatment at the beginning of the course of infection “.
The green light was given to treat Regeneron, called Regen-Cove-2, which is a combination of two antibodies, after it was shown to reduce cases of Covid-19 that require hospitalization or emergency rooms.
[ad_2]
